Skip to main content
DONGSUNG PHARMACEUTICAL CO.,LTD logo

DONGSUNG PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 002210 ISIN · KR7002210003 KO Manufacturing
Open in API
Filings indexed 367 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KR South Korea
Listing KO 002210

About DONGSUNG PHARMACEUTICAL CO.,LTD

http://dongsung-pharm.com/user-english/

Dongsung Pharmaceutical Co., Ltd., established in 1957, develops, manufactures, and markets a diverse range of products across pharmaceuticals, cosmetics, and hair care. The company's pharmaceutical division produces over-the-counter (OTC) drugs and is expanding into health functional foods. Its portfolio also includes a variety of cosmetic products and is particularly known for its hair dyes. Dongsung Pharmaceutical focuses on developing nature-friendly products and is engaged in advanced research, including photodynamic therapy (PDT) for potential cancer treatments.

Recent filings

Filing Released Lang Actions
[기재정정]감사보고서제출
Regulatory Filings
2026-04-30 Korean
[기재정정]감사보고서제출
Regulatory Filings
2026-04-30 Korean
[기재정정]주요사항보고서(감자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a Korean ‘주요사항보고서(감자 결정)’ (major event report on a capital reduction) with corrections to the originally filed report. It details the decision to reduce share capital (감자 결정), including dates, share counts, and procedural notes. This is clearly an announcement of a change in the company’s capital structure. According to the categories, announcements relating to new share issues, stock splits, or other capital changes fall under ‘Share Issue/Capital Change’ (SHA).
2026-04-29 Korean
[기재정정]주요사항보고서(감자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a Korean Major Event Report (주요사항보고서) concerning a capital reduction (감자 결정) and specifically a correction (정정신고) to a prior share cancellation disclosure. This is an announcement of a change in the company’s capital structure (share cancellation), which matches the ‘Share Issue/Capital Change’ category (SHA).
2026-04-24 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a Korean regulatory disclosure announcing the conclusion (and subsequent amendment) of a single sales and supply contract (contract details, amounts, dates, counterparty, etc.). It is not an annual or interim financial report, earnings release, management change, or any share/capital transaction. There is no specific category for contract announcements, so it falls under the general regulatory filings (RNS) fallback.
2026-04-22 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a Korean ‘주요사항보고서(유상증자결정)’ – a Material Information Report on a paid-in capital increase decision. It details the issuance of new shares (type, number, price, third-party allotment, use of proceeds, etc.) and even corrects a prior submission. This matches our Share Issue/Capital Change category (SHA).
2026-04-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.